Cisplatin

protein tyrosine phosphatase non-receptor type 11 ; Homo sapiens







10 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 32646966 The YAP-Interacting Phosphatase SHP2 Can Regulate Transcriptional Coactivity and Modulate Sensitivity to Chemotherapy in Cholangiocarcinoma. 2020 Oct 2
2 31564571 Shp2 expression is upregulated in cervical cancer, and Shp2 contributes to cell growth and migration and reduces sensitivity to cisplatin in cervical cancer cells. 2019 Nov 4
3 29207183 Src homology phosphotyrosyl phosphatase 2 mediates cisplatin-related drug resistance by inhibiting apoptosis and activating the Ras/PI3K/Akt1/survivin pathway in lung cancer cells. 2018 Feb 9
4 28085101 Shp2 Inhibits Proliferation of Esophageal Squamous Cell Cancer via Dephosphorylation of Stat3. 2017 Jan 12 1
5 28423588 Shp2 confers cisplatin resistance in small cell lung cancer via an AKT-mediated increase in CA916798. 2017 Apr 4 8
6 25561980 Effects of mitochondrial translocation of telomerase on drug resistance in hepatocellular carcinoma cells. 2015 2
7 23189174 Novel functions of the phosphatase SHP2 in the DNA replication and damage checkpoints. 2012 1
8 19909727 Selective activation of SHP2 activity by cisplatin revealed by a novel chemical probe-based assay. 2010 Jan 1 7
9 16260787 SHP-2 phosphatase regulates DNA damage-induced apoptosis and G2/M arrest in catalytically dependent and independent manners, respectively. 2005 Dec 30 3
10 12594211 Role of SHP-2 tyrosine phosphatase in the DNA damage-induced cell death response. 2003 Apr 25 1